|
1
|
Torphy RJ, Fujiwara Y and Schulick RD:
Pancreatic cancer treatment: Better, but a long way to go. Surg
Today. 50:1117–1125. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kolbeinsson HM, Chandana S, Wright GP and
Chung M: Pancreatic cancer: A review of current treatment and novel
therapies. J Invest Surg. 36:21298842023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leidner R, Sanjuan Silva N, Huang H,
Sprott D, Zheng C, Shih YP, Leung A, Payne R, Sutcliffe K, Cramer
J, et al: Neoantigen T-cell receptor gene therapy in pancreatic
cancer. N Engl J Med. 386:2112–2119. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bhatia R, Bhyravbhatla N, Kisling A, Li X,
Batra SK and Kumar S: Cytokines chattering in pancreatic ductal
adenocarcinoma tumor microenvironment. Semin Cancer Biol.
86:499–510. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zimnoch L, Szynaka B and Puchalski Z: Mast
cells and pancreatic stellate cells in chronic pancreatitis with
differently intensified fibrosis. Hepatogastroenterology.
49:1135–1138. 2002.PubMed/NCBI
|
|
6
|
Jin C, Duan X, Liu Y, Zhu J, Zhang K,
Zhang Y, Xia T, Fei Y and Ye J: T cell immunity induced by a
bivalent Salmonella-based CEACAM6 and 4-1BBL vaccines in a rat
colorectal cancer model. Oncol Lett. 13:3753–3759. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dong C: Cytokine regulation and function
in T cells. Annu Rev Immunol. 39:51–76. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu X and Zhu J: CD4 T helper cell subsets
and related human immunological disorders. Int J Mol Sci.
21:80112020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kumar S, Jeong Y, Ashraf MU and Bae YS:
Dendritic cell-mediated Th2 Immunity and immune disorders. Int J
Mol Sci. 20:21592019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang W, Sung N, Gilman-Sachs A and
Kwak-Kim J: T Helper (Th) Cell profiles in pregnancy and recurrent
pregnancy losses: Th1/Th2/Th9/Th17/Th22/Tfh cells. Front Immunol.
11:20252020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Alspach E, Lussier DM and Schreiber RD:
Interferon γ and its important roles in promoting and inhibiting
spontaneous and therapeutic cancer immunity. Cold Spring Harb
Perspect Biol. 11:a0284802019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
McGeachy MJ, Cua DJ and Gaffen SL: The
IL-17 family of cytokines in health and disease. Immunity.
50:892–906. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Razi S, Baradaran Noveiry B,
Keshavarz-Fathi M and Rezaei N: IL-17 and colorectal cancer: From
carcinogenesis to treatment. Cytokine. 116:7–12. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee YH, Chuah S, Nguyen PHD, Lim CJ, Lai
HLH, Wasser M, Chua C, Lim TKH, Leow WQ, Loh TJ, et al: IFNγ-IL-17+
CD8 T cells contribute to immunosuppression and tumor progression
in human hepatocellular carcinoma. Cancer Lett. 552:2159772023.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Claus C, Ferrara C, Xu W, Sam J, Lang S,
Uhlenbrock F, Albrecht R, Herter S, Schlenker R, Hüsser T, et al:
Tumor-targeted 4-1BB agonists for combination with T cell
bispecific antibodies as off-the-shelf therapy. Sci Transl Med.
11:eaav59892019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cho E, Singh R, Han C, Kim SH, Kim KH,
Park BM, Shin DH, Han S, Kim YH, Kwon BS, et al: 4-1BB-4-1BBL
cis-interaction contributes to the survival of self-reactive
CD8+ T cell. Cell Mol Immunol. 20:1077–1080. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Martinez-Perez AG, Perez-Trujillo JJ,
Garza-Morales R, Loera-Arias MJ, Saucedo-Cardenas O, Garcia-Garcia
A, Rodriguez-Rocha H and Montes-de-Oca-Luna R: 4-1BBL as a mediator
of cross-talk between innate, adaptive, and regulatory immunity
against cancer. Int J Mol Sci. 22:621012021. View Article : Google Scholar
|
|
18
|
Zhu H, Wang M, Du Y, Liu X, Weng X and Li
C: 4-1BBL has a possible role in mediating castration-resistant
conversion of prostate cancer via up-regulation of androgen
receptor. J Cancer. 10:2464–2471. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
An HW, Seok SH, Kwon JW, Choudhury AD, Oh
JS, Voon DC, Kim DY and Park JW: The loss of epithelial Smad4
drives immune evasion via CXCL1 while displaying vulnerability to
combinatorial immunotherapy in gastric cancer. Cell Rep.
41:1118782022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Puigdelloses M, Garcia-Moure M, Labiano S,
Laspidea V, Gonzalez-Huarriz M, Zalacain M, Marrodan L,
Martinez-Velez N, De la Nava D, Ausejo I, et al: CD137 and PD-L1
targeting with immunovirotherapy induces a potent and durable
antitumor immune response in glioblastoma models. J Immunother
Cancer. 9:e0026442021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun Y, Hu H, Liu Z, Xu J, Gao Y, Zhan X,
Zhou S, Zhong W, Wu D, Wang P, et al: Macrophage STING signaling
promotes NK cell to suppress colorectal cancer liver metastasis via
4-1BBL/4-1BB co-stimulation. J Immunother Cancer. 11:e0064812023.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC cancer staging manual. 7th edition.
Springer; New York, NY: 2010
|
|
23
|
Nagtegaal ID, Odze RD, Klimstra D, Paradis
V, Rugge M, Schirmacher P, Washington KM, Carneiro F and Cree IA;
WHO Classification of Tumours Editorial Board, : The 2019 WHO
classification of tumours of the digestive system. Histopathology.
76:182–188. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma Y, Ma L, Guo Q and Zhang S: Expression
of bone morphogenetic protein-2 and its receptors in epithelial
ovarian cancer and their influence on the prognosis of ovarian
cancer patients. J Exp Clin Cancer Res. 29:852010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Galon J, Costes A, Sanchez-Cabo F,
Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M,
Berger A, Wind P, et al: Type, density, and location of immune
cells within human colorectal tumors predict clinical outcome.
Science. 313:1960–1964. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Roxburgh CSD and McMillan DC: The role of
the in situ local inflammatory response in predicting recurrence
and survival in patients with primary operable colorectal cancer.
Cancer Treat Rev. 38:451–466. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li F, Chen B, Li L, Zha M, Zhou S, Wu T,
Bachem MG and Sun Z: INS-1 cells inhibit the production of
extracellular matrix from pancreatic stellate cells. J Mol Histol.
45:321–327. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Q, Yang Q, Wu Z, Chen Y, Xu M, Zhang
H, Zhao J, Liu Z, Guan Z, Luo J, et al: IL-1β-activated mTORC2
promotes accumulation of IFN-γ+ γδ T cells by
upregulating CXCR3 to restrict hepatic fibrosis. Cell Death Dis.
13:2892022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ren J, Li N, Pei S, Lian Y, Li L, Peng Y,
Liu Q, Guo J, Wang X, Han Y, et al: Histone methyltransferase WHSC1
loss dampens MHC-I antigen presentation pathway to impair
IFN-γ-stimulated antitumor immunity. J Clin Invest.
132:e1531672022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee JW, Wang P, Kattah MG, Youssef S,
Steinman L, DeFea K and Straus DS: Differential regulation of
chemokines by IL-17 in colonic epithelial cells. J Immunol.
181:6536–6545. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Benchetrit F, Ciree A, Vives V, Warnier G,
Gey A, Sautès-Fridman C, Fossiez F, Haicheur N, Fridman WH and
Tartour E: Interleukin-17 inhibits tumor cell growth by means of a
T-cell-dependent mechanism. Blood. 99:2114–2121. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu N, Wang Y, Wang K, Zhong B, Liao Y,
Liang J and Jiang N: Cathepsin K regulates the tumor growth and
metastasis by IL-17/CTSK/EMT axis and mediates M2 macrophage
polarization in castration-resistant prostate cancer. Cell Death
Dis. 13:8132022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gorczynski RM: IL-17 signaling in the
tumor microenvironment. Birbrair A: Tumor Microenvironment.
Advances in Experimental Medicine and Biology. Vol 1240. Springer;
Cham: pp. pp47–58. 2020, View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shen X, Zhang R, Nie X, Yang Y, Hua Y and
Lü P: 4-1BB targeting immunotherapy: Mechanism, antibodies, and
chimeric antigen receptor T. Cancer Biother Radiopharm. 38:431–444.
2023.PubMed/NCBI
|
|
36
|
Ye JX, Zhang YT, Zhang XG, Ren DM and Chen
WC: Recombinant attenuated Salmonella harboring 4-1BB ligand gene
enhances cellular immunity. Vaccine. 27:1717–1723. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ye J, Li L, Zhang Y, Zhang X, Ren D and
Chen W: Recombinant Salmonella-based 4-1BBL vaccine enhances T cell
immunity and inhibits the development of colorectal cancer in rats:
In vivo effects of vaccine containing 4-1BBL. J Biomed Sci.
20:82013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Leech MD, Barr TA, Turner DG, Brown S,
O'Connor RA, Gray D, Mellanby RJ and Anderton SM: Cutting edge:
IL-6-dependent autoimmune disease: Dendritic cells as a sufficient,
but transient, source. J Immunol. 190:881–885. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hingorani SR: Epithelial and stromal
co-evolution and complicity in pancreatic cancer. Nat Rev Cancer.
23:57–77. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu C, He D, Li L, Zhang S, Wang L, Fan Z
and Wang Y: Extracellular vesicles in pancreatic cancer immune
escape: Emerging roles and mechanisms. Pharmacol Res.
183:1063642022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Picard FSR, Lutz V, Brichkina A, Neuhaus
F, Ruckenbrod T, Hupfer A, Raifer H, Klein M, Bopp T, Pfefferle PI,
et al: IL-17A-producing CD8+ T cells promote PDAC via
induction of inflammatory cancer-associated fibroblasts. Gut.
72:1510–1522. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Teramatsu K, Oono T, Oyama K, Fujimori N,
Murakami M, Yasumori S, Ohno A, Matsumoto K, Takeno A, Nakata K, et
al: Circulating CD8+CD122+ T cells as a
prognostic indicator of pancreatic cancer. BMC Cancer. 22:11342022.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Song Y, Ji B, Jiang CX, Chen ZM, Yao NH,
Mukaida N and Huang H: IL17RB expression might predict prognosis
and benefit from gemcitabine in patients with resectable pancreatic
cancer. Pathol Res Pract. 215:1526502019. View Article : Google Scholar : PubMed/NCBI
|
